Second long term HRT trial stopped earlyBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7371.987 (Published 02 November 2002) Cite this as: BMJ 2002;325:987
- Caroline White
A second trial looking into the long term effects of hormone replacement therapy (HRT) has been stopped early.
The UK Medical Research Council (MRC) announced last week that a decision had been taken to halt the women's international study of long duration oestrogen after menopause (WISDOM) for “scientific and practical reasons.” The trial, which has cost £10m ($15.5m; €15.9m), was due to be completed in 2016.
WISDOM was investigating the long term effects of oestrogen combined with progestogen and of oestrogen alone on the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial